| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |